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Rats were made physically dependent on methaqualone by the use of the drug-admixed food (DAF) method for 33 days. Pentobarbital, barbital, ethanol and diazepam were cross-administered against methaqualone to evaluate the degree of suppression of methaqualone withdrawal signs as an index for the cross-physical dependence liability of these drugs to methaqualone. To evaluate the cross-physical dependence liability, we used AUC of body weight loss and withdrawal scores be tween the first cross-administration (9 hr after the withdrawal) and 27 hr after the withdrawal.
AUC of weight loss was significantly suppressed by the four test drugs as compared to each control.
Withdrawal scores were also significantly inhibited by the cross-administration of barbital, ethanol and diazepam. Considering that the rats given barbital or ethanol fell asleep after the cross-administration, diazepam seems to cause the strongest suppression of methaqualone withdrawal signs among the four test drugs.
Thus, physical dependence on methaqualone may be similar by nature to that on benzodiazepines rather than barbiturates and alcohol.
Misuses of methaqualone, a quinazolone derivative hypnotic, for non-medical purposes appear to be quite widespread as suggested by surveys carried out by various workers (1-4). Methaqualone has been reported to cause dependence in man (5-7). Physical dependence develops from the chronic use of methaqualone at doses of above 7.5 g daily. The doses of 2 g daily of methaqualone used for one month is sufficient to produce with drawal seizures (8).
In laboratory animals such as dogs (9, 10), rats (11, 12) and mice (13), evidence for physical dependence on methaqualone has been reported. Severe physical dependence on methaqualone, as manifested by spon taneous convulsions after its withdrawal, has not been however documented, suggesting that physical dependence on methaqualone is a mild type. Moreover, Yanagita and Miya sato (14) found that methaqualone produced no physical dependence in rhesus monkeys, but functioned as a reinforcer for monkeys in an intravenous self-administration procedure. However, Suzuki et al. (15) 
Materials and Methods

Animals:
Male Sprague-Dawley rats weighing 150-200 g at the beginning of the experiment were used. Animals were housed in individual cages under a 12-hr light-dark cycle with food and water continuously available. The room temperature was main tained at 22±1 °C, and the relative humidity was maintained at 55±5%. The rats were allowed to adapt to their environment for a period of 1 week.
Development of physical dependence: For preparing the drug-admixed food, methaqual one was mixed with a normal powdered food (CA-1, Japan Clea, Tokyo) in a mortar (20, 21) . Each rat was allowed to eat the meth aqualone-admixed food and to drink tap water ad libitum. For developing the physical dependence on methaqualone, the rats were chronically treated with methaqualone ac cording to the method of Suzuki et al. (15) . The concentration of methaqualone in the food was gradually increased from 1 and 2 to 10 and 1 2 mg/g of food for 33 days.
ED50 of test drugs in rotarod performance test: Motor incoordination was evaluated by the rotarod performance test (9 cm in diameter, 5.3 rpm; Natsume Seisakusho Co., Tokyo) in naive rats. Motor incoordination was assessed by the complete inability of the animal to walk on the rotarod in each of three trials. Median effective doses (ED50) for motor impairment were calculated by the up and down method (22). Rats were examined by the rotarod performance test after adminis tration of pentobarbital (at 15 min after i.p.), barbital (30 min after i.p.), ethanol (15 min after i.p.) and diazepam (45 min after p.o.).
Cross-physical dependence on test drugs: Withdrawal was conducted by substituting normal food for methaqualone-admixed food at 14:00 of the last day of the treatment in all rats. Cross-administration of test drugs was started from 9 hr after the methaqualone withdrawal.
The dose of ED50 for motor impairment was used for cross-adminis tration as the minimal dose of each drug.
Three doses of each test drug and saline or 0.5% CIVIC as the respective control were ad ministered with the same schedule. Pento barbital (25.4, 33.0 and 42.9 mg/kg, i.p.) was administered 8 times at 1.5-hr intervals until 16.5 hr after the withdrawal.
Barbital (156, 203 and 264 mg/kg, i.p.) was administered only once at 9 hr after the withdrawal. Ethanol (2.18, 2.83 and 3.68 g/kg, i.p.) and diazepam (65.0, 84.5 and 109.9 mg/kg, p.o.) were ad ministered twice at 9 and 15 hr after the withdrawal.
During and after the cross-administration, body weight and food intake were measured every 3 hr and withdrawal signs were ob served. Suppression of body weight loss by the cross-administration was used as an index for the evaluation of cross-physical de pendence liability to test drugs. The area under the curve (AUC) of weight loss was calculat ed by percent change in weight loss between the starting point of cross-administration of the test drugs (9 hr after the withdrawal) and 27 hr after the methaqualone withdrawal. Moreover, the following rating score for withdrawal signs was used according to the method of Tagashira et al. (23) , with a minor modification.
The withdrawal signs were classified into four grades: no abnormality (score 0), mild (score 1), intermediate (score 2) and severe (score 3).
Statistical analysis: Analysis for the in cidence of withdrawal signs was performed by the chi-square (2 x 2) test. All other analyses were carried out using Student's t-test.
Results
Pentobarbital:
The cross-administration with three doses (25.4, 33.0 and 42.9 mg/kg) of pentobarbital caused a slight inhibition of body weight loss by methaqualone with drawal.
However, body weight did not increase by pentobarbital injections and gradually kept decreasing (Fig. 1) . AUCs of weight loss for 25.4, 33.0, 42.9 mg/kg of pentobarbital and the control were 69.38+ 9.83, 65.02+21.14, 88.01 +14.40 and 128.15±18.04, respectively (Fig. 2) . The AUC of weight loss at the lowest dose of pento barbital, 25.4 mg/kg, was significantly smaller than that in the control. Straub's tail reaction was significantly inhibited at 33.0 and 42.9 Each test drug was cross-administered from 9 hr after the methaqualone withdrawal.
The arrows indicate the cross-administration of the test drugs and saline or 0.5% CIVIC. The dotted line represents that one rat died. Fig. 2 . Effects of several sedative-hypnotics on body weight loss after the methaqualone withdrawal. Cross-physical dependence liability of these drugs was evaluated by AUC. AUC of weight loss was calculated by changes of body weight between the starting point of cross-administration (9 hr after the withdrawal) and 27 hr after the withdrawal.
The numerals near the columns represent the doses of drugs. C: control. (Table 4 ). There were signifi cant differences in the withdrawal scores be tween all the 3 doses of diazepam and the control. 
Discussion
The cross-physical dependence test has been widely used to evaluate the physical dependence liability of sedative-hypnotics because it can be done quickly and economi cally (9, (17) (18) (19) .
In the present study, the cross-physical dependence test was used to investigate the characteristics of physical dependence on methaqualone. We made methaqualone-dependent rats by the DAF method and then examined the degree of sup pression of the methaqualone withdrawal signs by cross-administration of test drugs. Barbital as a long-acting barbiturate, pento barbital as a short-acting barbiturate, ethanol as alcohol and diazepam as a benzodiazepine were evaluated for the liability of cross-physi cal dependence.
According to the classifica tion of dependence-producing drugs by WHO, barbital, pentobarbital and diazepam belong to the barbiturate type (16). However, ethanol belongs to a different type, the alcohol type, which nevertheless possesses cross-physical dependence liability to the barbiturate type (17).
The cross-administration of test drugs was performed from 9 hr after the termination of methaqualone treatment, because several signs of methaqualone withdrawal started to be observed from approximately 9 hr after the withdrawal.
The ED50 for motor impairment was used for cross-administration as the minimal dose of each drug because there is high correlation between motor impairment by sedative hypnotics and severity of withdrawal signs after the termination of drug treatment (24).
The present study showed that all the four test drugs (barbital, pentobarbital, ethanol 
